Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Journal of Neurology, Neurosurgery, and Psychiatry|December 4, 2025
Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stagesMatej Perovnik, Urban Simončič, Jan Jamšek, et al.
JAMA Neurology|August 30, 2016
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson DiseaseMarie Y Davis, Catherine O Johnson, James B Leverenz, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Neurology|December 15, 2017
Recommendations of the Global Multiple System Atrophy Research Roadmap MeetingRyan R Walsh, Florian Krismer, Wendy R Galpern, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onsetNancy S Wexler, Judith Lorimer, Julie Porter, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
Pageof 27